PARVA and melanoma: Consistent with our results, A-to-I editing of miR-378a-3p in melanoma occurs in nonmetastatic but not metastatic cells, where the edited isoform uniquely targets the oncogene PARVA to suppress malignant progression, a property absent in the unedited form (44).